PATENT DUCTUS ARTERIOSUS

TRANSCATHETER CLOSURE OF PATENT DUCTUS ARTERIOSUS USING AMPLATZER DUCT OCCLUDER: INITIAL EXPERIENCE AT FAISALABAD INSTITUTE OF CARDIOLOGY

Abstract

Background: Device closure of Patent ductus arteriosus (PDA) using Amplatzer
Duct Occluder (ADO) is a well-known modality to treat PDA with limited complications
Objectives: To assess the efficacy, safety and immediate complications of percutaneous device
closure of PDA using Amplatzer Duct Occluder. Study Design: Descriptive case series. Place
and Duration of Study: Paediatric Cardiology Department of Faisalabad Institute of Cardiology,
Faisalabad from May, 2012 to July, 2017. Methods: All consecutive patients undergoing
cardiac catheterization for device closure were included. Detailed Echocardiography was done
by dedicated pediatric cardiologist before the procedure. Successfulness of procedure and
problems were recorded. Results: Out of 74 patients two had unsuitable anatomy for device
occlusion so were excluded while 72 patients underwent successful device closure. Complete
occlusion was achieved in all cases (100%) without any residual leak. There was not a single
case of device embolization, LPA obstruction or Coarctation of aorta while upper end of device
protruded in descending aorta in12 patients (8.45%) with no obstruction in descending aorta.
Three patients lost lower limb arterial pulse (4.17%) and one patient had week pulse (1.39%)
but pulses revived after injection heparin and streptokinase. Conclusion: Device closure of
PDA using Amplatzer Duct Occluder is a safe and effective therapeutic modality with minimal
complications